Profile
Yin Man Tang worked as a Portfolio Manager at Hindsight Investment Management (HK) Ltd.
Prior to that, he was the Chief Financial Officer at Pacific Century Premium Developments Ltd.
from 2014 to 2021.
Before that, he worked as a Director at Eclipse Bioinnovations, Inc. Mr. Tang completed his undergraduate degree at Brunel University and earned an MBA from The University of Nottingham.
Former positions of Yin Man Tang
| Companies | Position | End |
|---|---|---|
| PACIFIC CENTURY PREMIUM DEVELOPMENTS LIMITED | Director of Finance/CFO | 04/11/2021 |
Eclipse Bioinnovations, Inc.
 Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation. | Director/Board Member | - |
| Hindsight Investment Management (HK) Ltd. | Portfolio Manager-Equities | - |
Training of Yin Man Tang
| Brunel University | Undergraduate Degree |
| The University of Nottingham | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PACIFIC CENTURY PREMIUM DEVELOPMENTS LIMITED | Finance |
| Private companies | 2 |
|---|---|
| Hindsight Investment Management (HK) Ltd. | |
Eclipse Bioinnovations, Inc.
Eclipse Bioinnovations, Inc. Packaged SoftwareTechnology Services Eclipse Bioinnovations, Inc. is a private biotechnology company that develops first-in-class technologies to accelerate the development of RNA genomics discoveries and medicines. The company is based in San Diego, CA. The company offers its end-to-end RNA genomics products as services and kits and also provides custom RNA genomics services for select partners. Laboratory at UC San Diego. Eclipse Bio is an RNA next-generation sequencing (NGS) company founded in 2017 based on technologies and algorithms developed in Dr. The company was founded by Alexander Shishkin, Peter Chu, and Eugene W. Yeo. Peter Chu has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Yin Man Tang
